| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 5.71e-06 | 4 | 20 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.28e-05 | 188 | 20 | 4 | GO:0005201 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.12e-08 | 109 | 20 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.58e-06 | 656 | 20 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.61e-06 | 658 | 20 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | mucus layer | 2.61e-06 | 3 | 20 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.43e-03 | 530 | 20 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 1.54e-03 | 61 | 20 | 2 | GO:0101003 | |
| Domain | VWFD | 1.73e-09 | 16 | 20 | 4 | PS51233 | |
| Domain | VWD | 1.73e-09 | 16 | 20 | 4 | SM00216 | |
| Domain | VWF_type-D | 1.73e-09 | 16 | 20 | 4 | IPR001846 | |
| Domain | VWD | 1.73e-09 | 16 | 20 | 4 | PF00094 | |
| Domain | WxxW_domain | 2.10e-08 | 6 | 20 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.10e-08 | 6 | 20 | 3 | PF13330 | |
| Domain | TIL | 2.30e-07 | 12 | 20 | 3 | PF01826 | |
| Domain | C8 | 2.30e-07 | 12 | 20 | 3 | PF08742 | |
| Domain | C8 | 2.98e-07 | 13 | 20 | 3 | SM00832 | |
| Domain | Unchr_dom_Cys-rich | 2.98e-07 | 13 | 20 | 3 | IPR014853 | |
| Domain | TIL_dom | 3.79e-07 | 14 | 20 | 3 | IPR002919 | |
| Domain | CTCK_1 | 8.48e-07 | 18 | 20 | 3 | PS01185 | |
| Domain | VWC_out | 1.01e-06 | 19 | 20 | 3 | SM00215 | |
| Domain | CT | 1.60e-06 | 22 | 20 | 3 | SM00041 | |
| Domain | Cys_knot_C | 2.38e-06 | 25 | 20 | 3 | IPR006207 | |
| Domain | CTCK_2 | 2.38e-06 | 25 | 20 | 3 | PS01225 | |
| Domain | VWFC_1 | 7.33e-06 | 36 | 20 | 3 | PS01208 | |
| Domain | VWC | 8.65e-06 | 38 | 20 | 3 | SM00214 | |
| Domain | VWFC_2 | 8.65e-06 | 38 | 20 | 3 | PS50184 | |
| Domain | VWF_dom | 1.17e-05 | 42 | 20 | 3 | IPR001007 | |
| Domain | Glyco_hormone_CN | 1.13e-04 | 15 | 20 | 2 | IPR006208 | |
| Domain | Cys_knot | 1.13e-04 | 15 | 20 | 2 | PF00007 | |
| Domain | VWC | 4.05e-04 | 28 | 20 | 2 | PF00093 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.61e-12 | 21 | 13 | 5 | MM15706 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 7.86e-10 | 16 | 13 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.03e-09 | 17 | 13 | 4 | M27412 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.48e-09 | 60 | 13 | 5 | MM15636 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.81e-09 | 23 | 13 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 6.43e-09 | 26 | 13 | 4 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.09e-08 | 109 | 13 | 5 | MM15164 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.09e-07 | 140 | 13 | 5 | M27484 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.35e-07 | 62 | 13 | 4 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.43e-07 | 68 | 13 | 4 | M27303 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 1.47e-06 | 1128 | 13 | 8 | M1036 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.46e-06 | 111 | 13 | 4 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.76e-06 | 143 | 13 | 4 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.09e-05 | 250 | 13 | 4 | M27554 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 8.93e-05 | 1389 | 13 | 7 | MM15307 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 1.16e-03 | 1475 | 13 | 6 | M19806 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.58e-03 | 65 | 13 | 2 | M39682 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.12e-13 | 18 | 20 | 5 | 18834073 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 3.97e-13 | 5 | 20 | 4 | 11062147 | |
| Pubmed | 1.63e-10 | 3 | 20 | 3 | 20065027 | ||
| Pubmed | 1.63e-10 | 3 | 20 | 3 | 23464473 | ||
| Pubmed | 1.63e-10 | 3 | 20 | 3 | 19718741 | ||
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 23807779 | ||
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 25638393 | ||
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 17471237 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 6.50e-10 | 4 | 20 | 3 | 22269464 | |
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 14984930 | ||
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 6.50e-10 | 4 | 20 | 3 | 18198997 | |
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 12676567 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 6.50e-10 | 4 | 20 | 3 | 29869461 | |
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 1.62e-09 | 5 | 20 | 3 | 16188033 | |
| Pubmed | 1.62e-09 | 5 | 20 | 3 | 18035521 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 1.62e-09 | 5 | 20 | 3 | 16475027 | |
| Pubmed | 3.25e-09 | 6 | 20 | 3 | 19110483 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 7513696 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 3.14e-07 | 2 | 20 | 2 | 23272068 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 17203232 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 3.14e-07 | 2 | 20 | 2 | 27729120 | |
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 3.14e-07 | 2 | 20 | 2 | 20731025 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 34058148 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 37146737 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 3.14e-07 | 2 | 20 | 2 | 23527003 | |
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 3.14e-07 | 2 | 20 | 2 | 14988081 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 16540890 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 15563276 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 36111525 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 17621824 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 3.14e-07 | 2 | 20 | 2 | 18475301 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 24317696 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 3.14e-07 | 2 | 20 | 2 | 27845589 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 11445551 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 22391959 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 3.14e-07 | 2 | 20 | 2 | 35776514 | |
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 3.14e-07 | 2 | 20 | 2 | 12527922 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 27435107 | ||
| Pubmed | Study of mucin turnover in the small intestine by in vivo labeling. | 3.14e-07 | 2 | 20 | 2 | 29636525 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 24327612 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 26871672 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 23832517 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 23832516 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 3.14e-07 | 2 | 20 | 2 | 20873538 | |
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 3.14e-07 | 2 | 20 | 2 | 21653907 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 3.14e-07 | 2 | 20 | 2 | 36427316 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 14690056 | ||
| Pubmed | Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma. | 3.14e-07 | 2 | 20 | 2 | 14594655 | |
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 3.14e-07 | 2 | 20 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 3.14e-07 | 2 | 20 | 2 | 11587997 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 3.14e-07 | 2 | 20 | 2 | 28607090 | |
| Pubmed | Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice. | 3.14e-07 | 2 | 20 | 2 | 19158956 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 3.14e-07 | 2 | 20 | 2 | 24332705 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 12820724 | ||
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 3.14e-07 | 2 | 20 | 2 | 34656442 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 17321686 | ||
| Pubmed | E-cadherin is required for intestinal morphogenesis in the mouse. | 3.27e-07 | 24 | 20 | 3 | 22766025 | |
| Pubmed | Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. | 8.77e-07 | 33 | 20 | 3 | 16618389 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 27776277 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 18300795 | ||
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 9.42e-07 | 3 | 20 | 2 | 23305535 | |
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 9.42e-07 | 3 | 20 | 2 | 34158522 | |
| Pubmed | Gene expression profiling of colorectal mucinous adenocarcinomas. | 9.42e-07 | 3 | 20 | 2 | 20485009 | |
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 9.42e-07 | 3 | 20 | 2 | 29604272 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 29286856 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 24714692 | ||
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 9.42e-07 | 3 | 20 | 2 | 19596978 | |
| Pubmed | Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast. | 9.42e-07 | 3 | 20 | 2 | 17333267 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 36675209 | ||
| Pubmed | Differences in the expression of mucins in various forms of cystitis glandularis. | 9.42e-07 | 3 | 20 | 2 | 17659847 | |
| Pubmed | Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. | 9.42e-07 | 3 | 20 | 2 | 19556605 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 11352827 | ||
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 9.42e-07 | 3 | 20 | 2 | 21455588 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 29802623 | ||
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 9.42e-07 | 3 | 20 | 2 | 20422702 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 24920497 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 18825309 | ||
| Pubmed | 1.71e-06 | 41 | 20 | 3 | 22675208 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 21596555 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 33154304 | ||
| Pubmed | ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. | 1.88e-06 | 4 | 20 | 2 | 31582416 | |
| Pubmed | Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. | 1.88e-06 | 4 | 20 | 2 | 12391274 | |
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 1.88e-06 | 4 | 20 | 2 | 24901817 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 1.88e-06 | 4 | 20 | 2 | 27298226 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 36367122 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 23619266 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 21647207 | ||
| Pubmed | MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. | 1.88e-06 | 4 | 20 | 2 | 21097527 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 23249391 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 22691042 | ||
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 1.88e-06 | 4 | 20 | 2 | 17401217 | |
| Pubmed | Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. | 1.88e-06 | 4 | 20 | 2 | 18258655 | |
| Pubmed | [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. | 1.88e-06 | 4 | 20 | 2 | 17991319 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 25298197 | ||
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 1.88e-06 | 4 | 20 | 2 | 20929551 | |
| Pubmed | 2.59e-06 | 47 | 20 | 3 | 11208732 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 17058067 | ||
| Pubmed | pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. | 3.14e-06 | 5 | 20 | 2 | 10611155 | |
| Cytoband | 11p15.5 | 1.83e-05 | 118 | 20 | 3 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.80e-03 | 564 | 20 | 3 | chr11p15 | |
| GeneFamily | CD molecules|Mucins | 1.62e-12 | 21 | 13 | 5 | 648 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.08e-07 | 158 | 20 | 5 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.55e-07 | 170 | 20 | 5 | M5880 | |
| Coexpression | NABA_MATRISOME | 6.08e-06 | 1008 | 20 | 7 | MM17056 | |
| Coexpression | NABA_MATRISOME | 6.83e-06 | 1026 | 20 | 7 | M5889 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_DN | 1.34e-05 | 196 | 20 | 4 | M13256 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.35e-05 | 738 | 20 | 6 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.49e-05 | 751 | 20 | 6 | M5885 | |
| CoexpressionAtlas | BM Top 100 - bronchus | 4.81e-05 | 76 | 20 | 3 | BM Top 100 - bronchus | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.09e-07 | 170 | 20 | 4 | 9bea81031cdfe45e8cddac3a3afd9ca6c331c45a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.09e-07 | 170 | 20 | 4 | 2c5a1469e5743870e96e6c2cc92f0c5096b79f51 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.75e-07 | 173 | 20 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-06 | 179 | 20 | 4 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-06 | 180 | 20 | 4 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-06 | 180 | 20 | 4 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-06 | 182 | 20 | 4 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.22e-06 | 183 | 20 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.25e-06 | 184 | 20 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 1.39e-06 | 189 | 20 | 4 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-06 | 192 | 20 | 4 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-06 | 192 | 20 | 4 | f627a3f43e2340c8ba502211940171f25c7ff436 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 1.48e-06 | 192 | 20 | 4 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | C_06|World / shred on cell type and cluster | 1.54e-06 | 194 | 20 | 4 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.64e-06 | 197 | 20 | 4 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.64e-06 | 197 | 20 | 4 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.64e-06 | 197 | 20 | 4 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-06 | 198 | 20 | 4 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-06 | 198 | 20 | 4 | 9c5d7852f03468394e726c444cac92a043fc6d0e | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.67e-06 | 198 | 20 | 4 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-06 | 198 | 20 | 4 | f95f38cc747fb3549a791288bf8d0518c049ac96 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 123 | 20 | 3 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-05 | 152 | 20 | 3 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.64e-05 | 158 | 20 | 3 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-05 | 159 | 20 | 3 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.90e-05 | 161 | 20 | 3 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.18e-05 | 164 | 20 | 3 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.47e-05 | 167 | 20 | 3 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.66e-05 | 169 | 20 | 3 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-05 | 171 | 20 | 3 | 48125d825ca2d7ef34564250f5b47d2a579e03c9 | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 5.97e-05 | 172 | 20 | 3 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-05 | 173 | 20 | 3 | d8e965ff7e9b758876ec1521c1ccedd739e8d673 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-05 | 173 | 20 | 3 | c2d973356c40e0284fd3bd7733a164b141c66008 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-05 | 175 | 20 | 3 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.28e-05 | 175 | 20 | 3 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-05 | 175 | 20 | 3 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-05 | 177 | 20 | 3 | 709235694cc711b9b79690e23c94577b2ae06811 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.50e-05 | 177 | 20 | 3 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.50e-05 | 177 | 20 | 3 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-05 | 177 | 20 | 3 | 7f9c2a45a994b32f15e5693f7cb873716a4eb568 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-05 | 178 | 20 | 3 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.61e-05 | 178 | 20 | 3 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 178 | 20 | 3 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-05 | 178 | 20 | 3 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 178 | 20 | 3 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | Club_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.61e-05 | 178 | 20 | 3 | be64d4be23fb96a4cdd7980c58880fdfe817747f | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.61e-05 | 178 | 20 | 3 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.72e-05 | 179 | 20 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Epithelial-Goblet|Control / Disease state, Lineage and Cell class | 6.83e-05 | 180 | 20 | 3 | 5293d23b8b8ea587239ffde561b70bad01632521 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 6.83e-05 | 180 | 20 | 3 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | Control-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 7.17e-05 | 183 | 20 | 3 | bdd461349a1ef43a015843937d26e8d3571ecc22 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-05 | 183 | 20 | 3 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 7.17e-05 | 183 | 20 | 3 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-05 | 183 | 20 | 3 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 184 | 20 | 3 | 4b864c74e2cf7e58d6bd151f955c43d72f035d52 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.29e-05 | 184 | 20 | 3 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | Control-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 7.41e-05 | 185 | 20 | 3 | 9a793e6016295a63820e9d7563f195494ac692e7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 185 | 20 | 3 | 4d0f3d86fab02c80093e62cb0c79c586c13c5412 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.77e-05 | 188 | 20 | 3 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-05 | 188 | 20 | 3 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.77e-05 | 188 | 20 | 3 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.77e-05 | 188 | 20 | 3 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 189 | 20 | 3 | b06471b1bebb990d5146bddfb8002401c6b099a0 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.89e-05 | 189 | 20 | 3 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 189 | 20 | 3 | a8246acf31f02c85421268245afb651aa8788f14 | |
| ToppCell | COVID-19-Epithelial_cells-Tuft-like|COVID-19 / group, cell type (main and fine annotations) | 7.89e-05 | 189 | 20 | 3 | 2ffbe79fe3c3f22b1cb4269726b9eb5519be84a7 | |
| ToppCell | Club|World / shred by cell class for parenchyma | 8.02e-05 | 190 | 20 | 3 | 1974d559d7fee6cb68065b18af8bd38b64910622 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 8.02e-05 | 190 | 20 | 3 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-05 | 190 | 20 | 3 | f39ce1678fc375eb2a3af781ddb772b0f12c5744 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 8.02e-05 | 190 | 20 | 3 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 8.02e-05 | 190 | 20 | 3 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-05 | 190 | 20 | 3 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-05 | 190 | 20 | 3 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | (7)_Epithelial-G_(Club-Clara_cells)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.02e-05 | 190 | 20 | 3 | 593fd1451038b155826a48de4caa38f44406d0b9 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.14e-05 | 191 | 20 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.14e-05 | 191 | 20 | 3 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-05 | 191 | 20 | 3 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-G_(Club-Clara_cells)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.27e-05 | 192 | 20 | 3 | c7c232545fad8ad327ab94bd0def8dc5daacd03d | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.27e-05 | 192 | 20 | 3 | c3707243c5590d852c9f28429c96f50a1fa6b0dc | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.27e-05 | 192 | 20 | 3 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.27e-05 | 192 | 20 | 3 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.40e-05 | 193 | 20 | 3 | 8ede7038a222c7e7ecaf7e86520823cf606cbee7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.40e-05 | 193 | 20 | 3 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.40e-05 | 193 | 20 | 3 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 8.40e-05 | 193 | 20 | 3 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.40e-05 | 193 | 20 | 3 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.40e-05 | 193 | 20 | 3 | 0e7d7adfaa7191e34038fcda6677561ae13934eb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.40e-05 | 193 | 20 | 3 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.53e-05 | 194 | 20 | 3 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.53e-05 | 194 | 20 | 3 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-05 | 194 | 20 | 3 | f4286ae7bb8350c42d50727ee8688b80129714f6 | |
| ToppCell | COPD-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 8.53e-05 | 194 | 20 | 3 | 72a2e0cba171ab59aa176e91a59a54c562af0390 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-05 | 194 | 20 | 3 | 87461bd6d7f702c0a0f5e0c8ace3049125a51f9a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-05 | 194 | 20 | 3 | c578cf7c6b4d6f31f87dde8845de5b3891f16822 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.66e-05 | 195 | 20 | 3 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.66e-05 | 195 | 20 | 3 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-05 | 195 | 20 | 3 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|World / Lineage and Cell class | 8.66e-05 | 195 | 20 | 3 | d53974d1866e23c894ffd492ea11d20422919b11 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.66e-05 | 195 | 20 | 3 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | normal_Lung-Epithelial_cells-Club|normal_Lung / Location, Cell class and cell subclass | 8.66e-05 | 195 | 20 | 3 | b46544ad5af04f4dbc2643637caa3d2d50d922ae | |
| Drug | Active Hexose Correlated Compound | 1.87e-06 | 28 | 20 | 3 | ctd:C499366 | |
| Drug | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | 2.05e-05 | 8 | 20 | 2 | ctd:C064545 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 2.23e-05 | 194 | 20 | 4 | 1239_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.27e-05 | 195 | 20 | 4 | 3571_DN | |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.32e-05 | 196 | 20 | 4 | 7269_DN | |
| Drug | haloperidol; Up 200; 10uM; PC3; HT_HG-U133A | 2.36e-05 | 197 | 20 | 4 | 1244_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 7272_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HG-U133A | 2.41e-05 | 198 | 20 | 4 | 23_DN | |
| Drug | 4-hydroxyretinoic acid | 4.81e-05 | 12 | 20 | 2 | ctd:C019429 | |
| Drug | Ovalbumin | 4.91e-05 | 82 | 20 | 3 | ctd:D010047 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.66e-09 | 5 | 20 | 3 | DOID:3030 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 9.50e-08 | 64 | 20 | 4 | DOID:4947 (is_marker_for) | |
| Disease | cystitis (is_marker_for) | 4.36e-07 | 2 | 20 | 2 | DOID:1679 (is_marker_for) | |
| Disease | sputum mucin-5B amount | 1.31e-06 | 3 | 20 | 2 | OBA_2050332 | |
| Disease | mucositis (biomarker_via_orthology) | 4.36e-06 | 5 | 20 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | idiopathic pulmonary fibrosis | 7.61e-06 | 57 | 20 | 3 | EFO_0000768 | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 9.15e-06 | 7 | 20 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 9.35e-06 | 61 | 20 | 3 | DOID:3587 (is_marker_for) | |
| Disease | cystic fibrosis (is_marker_for) | 9.82e-06 | 62 | 20 | 3 | DOID:1485 (is_marker_for) | |
| Disease | common bile duct neoplasm (is_marker_for) | 1.22e-05 | 8 | 20 | 2 | DOID:4608 (is_marker_for) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 1.57e-05 | 9 | 20 | 2 | EFO_0009824 | |
| Disease | otitis media (is_marker_for) | 1.96e-05 | 10 | 20 | 2 | DOID:10754 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 1.96e-05 | 10 | 20 | 2 | DOID:11204 (is_marker_for) | |
| Disease | pulmonary fibrosis | 2.39e-05 | 11 | 20 | 2 | EFO_0009448 | |
| Disease | otitis media (biomarker_via_orthology) | 5.90e-05 | 17 | 20 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | COVID-19 symptoms measurement | 2.56e-04 | 35 | 20 | 2 | EFO_0600019 | |
| Disease | pneumonia | 4.63e-04 | 47 | 20 | 2 | EFO_0003106 | |
| Disease | interstitial lung disease | 9.40e-04 | 67 | 20 | 2 | EFO_0004244 | |
| Disease | Inhalant adrenergic use measurement | 1.92e-03 | 96 | 20 | 2 | EFO_0009941 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.96e-03 | 97 | 20 | 2 | DOID:3083 (is_marker_for) | |
| Disease | susceptibility to pneumonia measurement | 1.96e-03 | 97 | 20 | 2 | EFO_0008410 | |
| Disease | Adenoid Cystic Carcinoma | 2.08e-03 | 100 | 20 | 2 | C0010606 | |
| Disease | pancreatic cancer (is_marker_for) | 2.12e-03 | 101 | 20 | 2 | DOID:1793 (is_marker_for) | |
| Disease | Drug Use Disorders | 2.73e-03 | 115 | 20 | 2 | C0013222 | |
| Disease | Drug Dependence | 2.73e-03 | 115 | 20 | 2 | C1510472 | |
| Disease | Drug habituation | 2.73e-03 | 115 | 20 | 2 | C0013170 | |
| Disease | Substance Dependence | 2.73e-03 | 115 | 20 | 2 | C0038580 | |
| Disease | Substance Use Disorders | 2.73e-03 | 115 | 20 | 2 | C0038586 | |
| Disease | Substance-Related Disorders | 2.73e-03 | 115 | 20 | 2 | C0236969 | |
| Disease | Drug abuse | 2.73e-03 | 115 | 20 | 2 | C0013146 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NTPPTTPESPSSVTV | 1021 | Q4LE39 | |
| TPATPTTPTGQQPTT | 1851 | Q09472 | |
| PTSLPTSPIIPTSGT | 586 | Q6ZN30 | |
| STPGTTPIPPVLTTT | 2151 | Q9HC84 | |
| PSSTPGTTPITPVLT | 4696 | Q9HC84 | |
| TFSTVPPTPPSITST | 931 | Q99102 | |
| SPPPTTSQTIISTIP | 4281 | Q99102 | |
| PDASPTVTTPTVTTP | 666 | Q66K74 | |
| PVTVSPTTPTSPTEG | 506 | Q9Y6G9 | |
| TTTTTTPPPTTTPSP | 1426 | Q02817 | |
| PITTTTTPLPTTTPS | 1441 | Q02817 | |
| TTTPSPPTTTTTTPP | 1481 | Q02817 | |
| PTTTTTTPPPTTTPS | 1526 | Q02817 | |
| TTTTTTPPPTTTPSP | 1606 | Q02817 | |
| PTTTPITPPTSTTTL | 1621 | Q02817 | |
| ITPPTSTTTLPPTTT | 1626 | Q02817 | |
| TLPPTTTSSPLTTTP | 1746 | Q02817 | |
| TTTTTENPTPPTTTP | 1886 | Q02817 | |
| ENPTPPTTTPITTTT | 1891 | Q02817 | |
| TVTPTPTPTGTQTPT | 1906 | Q02817 | |
| PTPTGTQTPTTTPIT | 1911 | Q02817 | |
| TPTPTPTGTQTPTTT | 1931 | Q02817 | |
| TTVTPTPTPTGTQTP | 1951 | Q02817 | |
| TPTPTGTQTPTTTPI | 1956 | Q02817 | |
| VTPTPTPTGTQTPTT | 1976 | Q02817 | |
| PTPTPTGTQTPTTTP | 2001 | Q02817 | |
| TVTPTPTPTGTQTPT | 2021 | Q02817 | |
| PTPTGTQTPTTTPIT | 2026 | Q02817 | |
| TPTPTPTGTQTPTTT | 2046 | Q02817 | |
| TTVTPTPTPTGTQTP | 2066 | Q02817 | |
| TPTPTGTQTPTTTPI | 2071 | Q02817 | |
| VTPTPTPTGTQTPTT | 2091 | Q02817 | |
| PTPTPTGTQTPTTTP | 2116 | Q02817 | |
| TVTPTPTPTGTQTPT | 2136 | Q02817 | |
| PTPTGTQTPTTTPIT | 2141 | Q02817 | |
| TPTPTPTGTQTPTTT | 2161 | Q02817 | |
| TTVTPTPTPTGTQTP | 2181 | Q02817 | |
| TPTPTGTQTPTTTPI | 2186 | Q02817 | |
| VTPTPTPTGTQTPTT | 2206 | Q02817 | |
| PTPTPTGTQTPTTTP | 2231 | Q02817 | |
| TVTPTPTPTGTQTPT | 2251 | Q02817 | |
| PTPTGTQTPTTTPIT | 2256 | Q02817 | |
| TPTPTPTGTQTPTTT | 2276 | Q02817 | |
| TTVTPTPTPTGTQTP | 2296 | Q02817 | |
| TPTPTGTQTPTTTPI | 2301 | Q02817 | |
| VTPTPTPTGTQTPTT | 2321 | Q02817 | |
| PTPTPTGTQTPTTTP | 2346 | Q02817 | |
| TVTPTPTPTGTQTPT | 2366 | Q02817 | |
| PTPTGTQTPTTTPIT | 2371 | Q02817 | |
| TPTPTPTGTQTPTTT | 2391 | Q02817 | |
| TTVTPTPTPTGTQTP | 2411 | Q02817 | |
| TPTPTGTQTPTTTPI | 2416 | Q02817 | |
| VTPTPTPTGTQTPTT | 2436 | Q02817 | |
| PTPTPTGTQTPTTTP | 2461 | Q02817 | |
| TVTPTPTPTGTQTPT | 2481 | Q02817 | |
| PTPTGTQTPTTTPIT | 2486 | Q02817 | |
| TPTPTPTGTQTPTTT | 2506 | Q02817 | |
| TTVTPTPTPTGTQTP | 2526 | Q02817 | |
| TPTPTGTQTPTTTPI | 2531 | Q02817 | |
| VTPTPTPTGTQTPTT | 2551 | Q02817 | |
| PTPTPTGTQTPTTTP | 2576 | Q02817 | |
| TVTPTPTPTGTQTPT | 2596 | Q02817 | |
| PTPTGTQTPTTTPIT | 2601 | Q02817 | |
| TPTPTPTGTQTPTTT | 2621 | Q02817 | |
| TTVTPTPTPTGTQTP | 2641 | Q02817 | |
| TPTPTGTQTPTTTPI | 2646 | Q02817 | |
| VTPTPTPTGTQTPTT | 2666 | Q02817 | |
| PTPTPTGTQTPTTTP | 2691 | Q02817 | |
| TVTPTPTPTGTQTPT | 2711 | Q02817 | |
| PTPTGTQTPTTTPIT | 2716 | Q02817 | |
| TPTPTPTGTQTPTTT | 2736 | Q02817 | |
| TTVTPTPTPTGTQTP | 2756 | Q02817 | |
| TPTPTGTQTPTTTPI | 2761 | Q02817 | |
| VTPTPTPTGTQTPTT | 2781 | Q02817 | |
| PTPTPTGTQTPTTTP | 2806 | Q02817 | |
| TVTPTPTPTGTQTPT | 2826 | Q02817 | |
| PTPTGTQTPTTTPIT | 2831 | Q02817 | |
| TPTPTPTGTQTPTTT | 2851 | Q02817 | |
| TTVTPTPTPTGTQTP | 2871 | Q02817 | |
| TPTPTGTQTPTTTPI | 2876 | Q02817 | |
| VTPTPTPTGTQTPTT | 2896 | Q02817 | |
| PTPTPTGTQTPTTTP | 2921 | Q02817 | |
| TVTPTPTPTGTQTPT | 2941 | Q02817 | |
| PTPTGTQTPTTTPIT | 2946 | Q02817 | |
| TPTPTPTGTQTPTTT | 2966 | Q02817 | |
| TTVTPTPTPTGTQTP | 2986 | Q02817 | |
| TPTPTGTQTPTTTPI | 2991 | Q02817 | |
| VTPTPTPTGTQTPTT | 3011 | Q02817 | |
| PTPTPTGTQTPTTTP | 3036 | Q02817 | |
| TVTPTPTPTGTQTPT | 3056 | Q02817 | |
| PTPTGTQTPTTTPIT | 3061 | Q02817 | |
| TPTPTPTGTQTPTTT | 3081 | Q02817 | |
| TTVTPTPTPTGTQTP | 3101 | Q02817 | |
| TPTPTGTQTPTTTPI | 3106 | Q02817 | |
| VTPTPTPTGTQTPTT | 3126 | Q02817 | |
| PTPTPTGTQTPTTTP | 3151 | Q02817 | |
| TVTPTPTPTGTQTPT | 3171 | Q02817 | |
| PTPTGTQTPTTTPIT | 3176 | Q02817 | |
| TPTPTPTGTQTPTTT | 3196 | Q02817 | |
| TTVTPTPTPTGTQTP | 3216 | Q02817 | |
| TPTPTGTQTPTTTPI | 3221 | Q02817 | |
| VTPTPTPTGTQTPTT | 3241 | Q02817 | |
| PTPTPTGTQTPTTTP | 3266 | Q02817 | |
| TVTPTPTPTGTQTPT | 3286 | Q02817 | |
| PTPTGTQTPTTTPIT | 3291 | Q02817 | |
| TPTPTPTGTQTPTTT | 3311 | Q02817 | |
| TTVTPTPTPTGTQTP | 3331 | Q02817 | |
| TPTPTGTQTPTTTPI | 3336 | Q02817 | |
| VTPTPTPTGTQTPTT | 3356 | Q02817 | |
| PTPTPTGTQTPTTTP | 3381 | Q02817 | |
| TVTPTPTPTGTQTPT | 3401 | Q02817 | |
| PTPTGTQTPTTTPIT | 3406 | Q02817 | |
| TPTPTPTGTQTPTTT | 3426 | Q02817 | |
| TTVTPTPTPTGTQTP | 3446 | Q02817 | |
| TPTPTGTQTPTTTPI | 3451 | Q02817 | |
| VTPTPTPTGTQTPTT | 3471 | Q02817 | |
| PTPTPTGTQTPTTTP | 3496 | Q02817 | |
| TVTPTPTPTGTQTPT | 3516 | Q02817 | |
| PTPTGTQTPTTTPIT | 3521 | Q02817 | |
| TPTPTPTGTQTPTTT | 3541 | Q02817 | |
| TTVTPTPTPTGTQTP | 3561 | Q02817 | |
| TPTPTGTQTPTTTPI | 3566 | Q02817 | |
| VTPTPTPTGTQTPTT | 3586 | Q02817 | |
| PTPTPTGTQTPTTTP | 3611 | Q02817 | |
| TVTPTPTPTGTQTPT | 3631 | Q02817 | |
| PTPTGTQTPTTTPIT | 3636 | Q02817 | |
| TPTPTPTGTQTPTTT | 3656 | Q02817 | |
| TTVTPTPTPTGTQTP | 3676 | Q02817 | |
| TPTPTGTQTPTTTPI | 3681 | Q02817 | |
| VTPTPTPTGTQTPTT | 3701 | Q02817 | |
| PTPTPTGTQTPTTTP | 3726 | Q02817 | |
| TVTPTPTPTGTQTPT | 3746 | Q02817 | |
| PTPTGTQTPTTTPIT | 3751 | Q02817 | |
| TPTPTPTGTQTPTTT | 3771 | Q02817 | |
| TTVTPTPTPTGTQTP | 3791 | Q02817 | |
| TPTPTGTQTPTTTPI | 3796 | Q02817 | |
| VTPTPTPTGTQTPTT | 3816 | Q02817 | |
| PTPTPTGTQTPTTTP | 3841 | Q02817 | |
| TVTPTPTPTGTQTPT | 3861 | Q02817 | |
| PTPTGTQTPTTTPIT | 3866 | Q02817 | |
| TPTPTPTGTQTPTTT | 3886 | Q02817 | |
| TTVTPTPTPTGTQTP | 3906 | Q02817 | |
| TPTPTGTQTPTTTPI | 3911 | Q02817 | |
| VTPTPTPTGTQTPTT | 3931 | Q02817 | |
| PTPTPTGTQTPTTTP | 3956 | Q02817 | |
| TVTPTPTPTGTQTPT | 3976 | Q02817 | |
| PTPTGTQTPTTTPIT | 3981 | Q02817 | |
| TPTPTPTGTQTPTTT | 4001 | Q02817 | |
| TTVTPTPTPTGTQTP | 4021 | Q02817 | |
| TPTPTGTQTPTTTPI | 4026 | Q02817 | |
| VTPTPTPTGTQTPTT | 4046 | Q02817 | |
| PTPTPTGTQTPTTTP | 4071 | Q02817 | |
| TVTPTPTPTGTQTPT | 4091 | Q02817 | |
| PTPTGTQTPTTTPIT | 4096 | Q02817 | |
| TPTPTPTGTQTPTTT | 4116 | Q02817 | |
| TTVTPTPTPTGTQTP | 4136 | Q02817 | |
| TPTPTGTQTPTTTPI | 4141 | Q02817 | |
| VTPTPTPTGTQTPTT | 4161 | Q02817 | |
| TTAPPVTTVTSQPPT | 266 | Q9H8J5 | |
| TTPSPVPTTSITSAP | 2346 | P98088 | |
| GPETTPSPVPTTSTT | 2391 | P98088 | |
| PGTTPSPVPTTSTIS | 2656 | P98088 | |
| PGTTPSPVPTTSTTS | 2696 | P98088 | |
| PTTSTTSVPGTTPSP | 2936 | P98088 | |
| TSVPGTTPSPVPTTS | 2941 | P98088 | |
| TTPSPVPTTSTISVP | 2946 | P98088 | |
| PGTTPSPVPTTSTTS | 2976 | P98088 | |
| GTTPSPIPTTSTTSP | 3121 | P98088 | |
| GPGTTPSPVPTTSTI | 3151 | P98088 | |
| PSPVPTTSTTSAPIT | 4321 | P98088 | |
| PGSTPSPVPTTSTTS | 4341 | P98088 | |
| PVVSLTVPSTSPPSS | 771 | Q6VY07 | |
| TTTPLPTTTTPRPTT | 1456 | Q4ZHG4 | |
| RTTTTTTPTPTTPIP | 1496 | Q4ZHG4 | |
| RPPTTTEPSTTATTP | 1571 | Q4ZHG4 | |
| GSSVPTTPTSSVSPP | 416 | Q2V2M9 | |
| PTTQPTTEPTTQPTI | 86 | P05155 | |
| TSVTPQPTPLTSEPS | 261 | Q6ZVF9 | |
| TTTPTPTTSLLPTEP | 366 | Q68BL7 | |
| PVTTSTQSNSTPTPP | 3606 | Q685J3 | |
| TTTTTTGLPTPPVPA | 731 | Q6ZNJ1 | |
| EPSITPVTSTIPPTS | 91 | O75554 | |
| PTCPVSTTGPTTSTP | 161 | Q6ZSZ6 |